Related Experiment Video
Updated: Jun 27, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
The Impact of an Advance RI-CTR Award on Tuberculosis Infection Management in Rhode Island
Daria Szkwarko1, Steven Kim1, Roberta Goldman1
1The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Objectives:
To evaluate the impact of a Rhode Island (RI) Latent Tuberculosis Infection (TB Infection) Extension of Community Healthcare Outcomes (ECHO) telementoring program on primary care clinicians' self- reported learning and performance.
Methods:
Utilizing an exploratory, sequential, mixed- methods design, we first conducted 24 qualitative interviews with RI primary care clinicians and nurses to identify TB infection management gaps. These findings informed the curriculum for a six-session RI TB Infection ECHO course launched in 2021. Participant learning and performance were evaluated using pre- and post-course-structured questionnaires and follow-up qualitative interviews.
Results:
Qualitative analysis revealed that participating clinicians felt comfortable with TB infection screening but lacked confidence in treatment initiation and selection. Following the ECHO course, participants demonstrated significant increases in self-reported confidence across the majority of TB infection practice areas (P<0.05). Notably, 75% of post-survey respondents reported making specific practice changes, such as adopting shorter treatment regimens and improving newer test interpretation.
Conclusions:
The mentored research award was instrumental in the establishment of the first Project ECHO hub at The Warren Alpert Medical School of Brown University. By achieving Level 5 (Performance) on Moore's Educational Framework through documented practice change, the program demonstrated that tele- mentoring can effectively democratize specialized TB infection knowledge. This framework has since scaled to a regional TB infection ECHO program.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Respiratory Syncytial Virus Disease
